Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,200
Closed -$1.52M 2188
2025
Q2
$1.52M Sell
11,200
-92,500
-89% -$12.2M ﹤0.01% 1507
2025
Q1
$13.8M Sell
103,700
-10,100
-9% -$1.29M 0.03% 596
2024
Q4
$12.9M Buy
113,800
+47,300
+71% +$5.47M 0.03% 631
2024
Q3
$7.58M Buy
66,500
+22,900
+53% +$2.51M 0.02% 864
2024
Q2
$4.53M Buy
43,600
+5,400
+14% +$573K 0.01% 1039
2024
Q1
$4.34M Buy
38,200
+9,300
+32% +$1.07M 0.01% 1047
2023
Q4
$3.18M Buy
+28,900
New +$2.89M 0.01% 1130
2021
Q3
Sell
-200
Closed -$23K 1875
2021
Q2
$23K Buy
+200
New +$23.3K ﹤0.01% 1913

Other funds holding ABT

Man Group's ABT Position: Q1 2026 in Review

Man Group increased its Abbott (ABT) stake by 504% in Q1 2026, buying an estimated $34.3M and bringing the position to 363,904 shares worth $37.4M. The position accounts for 0.07% of the portfolio, ranked #293.

Man Group first reported a position in ABT in Q1 2018 and has held it in 30 quarters since. The position peaked at $126M in Q1 2022. 3,087 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Man Group held 363,904 shares of Abbott worth $37.4M as of Q1 2026.
  • Man Group bought 303,631 Abbott shares in Q1 2026, an estimated $34.3M.
  • Abbott made up 0.07% of Man Group's portfolio in Q1 2026, its #293 holding.
  • Man Group first reported a position in Abbott in Q1 2018 and has held it in 30 quarters since.
  • Man Group's Abbott position peaked at $126M in Q1 2022.
  • 3,087 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.